MedCity News August 8, 2023
Marissa Plescia

Through Scripta Insights’ app, members of its customers can input the medications they’re taking, and the company will provide a savings report that will show different options on how they can save on their prescriptions. Starting in 2024, Cost Plus Drugs may show up as an option in the savings report.

About 28% of Americans experience difficulty affording their prescription drugs, and 31% don’t take their medication as prescribed because of cost, according to KFF. A new partnership is addressing this issue.

Scripta Insights, a prescription navigation company, announced last week it is now working with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs), a mail-order pharmacy. Boston-based Scripta Insights works with self-insured employers and health plans to help...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Partnerships, Pharma, Pharma / Biotech, Technology, Trends
Pharma Pulse 3/14/25: Navigating Internal Constraints and Uncertainty, Health Plan Support During Natural Disasters & more
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Roche builds in obesity with $5.3bn Zealand licensing deal

Share This Article